AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12821550 — intervention group
Group type: EXPERIMENTAL
Intervention: Late gadolinium enhancement with CMR in patients with DCM (63 patients)
Number of subjects: 90
Study 12821550 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 subjects)
Number of subjects: 90
Study 10377608 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental blackcurrant juice drink with calcium
Number of subjects: 12
Study 10377608 — intervention group
Group type: COMPARATOR
Intervention: Orange juice
Number of subjects: 12
Study 10377608 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study 10377608 — intervention group
Group type: COMPARATOR
Intervention: Proprietary blackcurrant juice drink
Number of subjects: 12
Study 10377608 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental blackcurrant juice drink with calcium (in vitro)
Number of subjects: 12
Study 10377608 — intervention group
Group type: COMPARATOR
Intervention: Orange juice (in vitro)
Number of subjects: 12
Study 10377608 — intervention group
Group type: COMPARATOR
Intervention: Water (in vitro)
Number of subjects: 12
Study 10377608 — intervention group
Group type: COMPARATOR
Intervention: Proprietary blackcurrant juice drink (in vitro)
Number of subjects: 12
Study 8882755 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin applied locally (30 microns), treatment given once a week for 5 consecutive weeks
Number of subjects: 15
Study 8882755 — intervention group
Group type: COMPARATOR
Intervention: Control group (equal number of patients)
Number of subjects: 15
Study 1944720 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral phosphatidylcholine at 900 mg/day for 8 weeks
Number of subjects: 8
Study 1944720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6416286 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) aerosol (10 mg) before exercise
Number of subjects: 12
Study 6416286 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) aerosol (10 mg) after exercise
Number of subjects: 12
Study 6416286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29161888 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% bird's nest fern extract (BNFE)
Number of subjects: 0
Study 29161888 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher polysaccharide content in BNFE
Number of subjects: 0
Study 29161888 — intervention group
Group type: EXPERIMENTAL
Intervention: BNFE
Number of subjects: 0
Study 28832179 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia educational intervention
Number of subjects: 200
Study 28832179 — intervention group
Group type: COMPARATOR
Intervention: Usual education (Control)
Number of subjects: 200
Study 26503077 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 h/day CCM treatment
Number of subjects: 19
Study 26503077 — intervention group
Group type: COMPARATOR
Intervention: 12 h/day CCM treatment
Number of subjects: 19
Study 24946625 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (5 times a week for 8 weeks)
Number of subjects: 126
Study 24946625 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 126
Study 22261571 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC; 1 g/d)
Number of subjects: 12
Study 22261571 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (Gln; 20 g/d)
Number of subjects: 12
Study 22261571 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (20 participants, 10 men and 10 women, aged 20-59 years)
Number of subjects: 12
Study 19921150 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-lactam antibiotic regimen (weekly cycling of ceftriaxone, amoxicillin-clavulanic acid)
Number of subjects: 0
Study 19921150 — intervention group
Group type: COMPARATOR
Intervention: Fluoroquinolone regimen
Number of subjects: 0
Study 17391168 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1 g twice daily
Number of subjects: 96
Study 17391168 — intervention group
Group type: COMPARATOR
Intervention: Repaglinide 2 mg thrice daily
Number of subjects: 96
Study 15755766 — intervention group
Group type: COMPARATOR
Intervention: Ghrelin concentrations in girls with AN
Number of subjects: 22
Study 15755766 — intervention group
Group type: COMPARATOR
Intervention: Secretory burst amplitude in girls with AN
Number of subjects: 22
Study 15755766 — intervention group
Group type: COMPARATOR
Intervention: Pulsatile ghrelin secretion in girls with AN
Number of subjects: 22
Study 15755766 — intervention group
Group type: COMPARATOR
Intervention: Fasting ghrelin in girls with AN
Number of subjects: 22
Study 15755766 — intervention group
Group type: COMPARATOR
Intervention: Valley ghrelin in girls with AN
Number of subjects: 22
Study 15755766 — intervention group
Group type: COMPARATOR
Intervention: Ghrelin parameters in girls with AN
Number of subjects: 22
Study 15755766 — intervention group
Group type: COMPARATOR
Intervention: Insulin resistance in girls with AN
Number of subjects: 22
Study 12041843 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling from specialized nurses using behavioural and lifestyle modification sessions every 4 weeks for 25 weeks
Number of subjects: 421
Study 12041843 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 421
Study 9620322 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cyclosporine monotherapy
Number of subjects: 104
Study 9620322 — intervention group
Group type: COMPARATOR
Intervention: Double-drug therapy (cyclosporine and steroids)
Number of subjects: 104
Study 8571077 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (30 mg per day)
Number of subjects: 30
Study 8571077 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2591470 — intervention group
Group type: EXPERIMENTAL
Intervention: Theo-Dur tablets with a balanced meal
Number of subjects: 12
Study 2591470 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilatrane A.P. with a balanced meal
Number of subjects: 12
Study 2591470 — intervention group
Group type: EXPERIMENTAL
Intervention: Theo-Dur tablets with a hyperlipidic meal
Number of subjects: 12
Study 2591470 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilatrane A.P. with a hyperlipidic meal
Number of subjects: 12
Study 807224 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 877
Study 31030946 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed lipid emulsion containing fish oil
Number of subjects: 230
Study 31030946 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil−based lipid emulsion (control)
Number of subjects: 230
Study 27613881 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco sold only at half the existing liquor stores
Number of subjects: 623
Study 27613881 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco sold only at pharmacies
Number of subjects: 623
Study 27613881 — intervention group
Group type: COMPARATOR
Intervention: Annual tobacco tax increases
Number of subjects: 623
Study 25359159 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine, titrated to target fasting plasma glucose of 4.0-5.5 mmol/L for 24 weeks
Number of subjects: 978
Study 25359159 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide, escalated to the highest approved clinical dose of 1.8 mg daily for 24 weeks
Number of subjects: 978
Study 23746076 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Mucosal Resection (EMR)
Number of subjects: 24
Study 23746076 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal Endoscopic Microsurgery (TEM)
Number of subjects: 24
Study 23746076 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Mucosal Resection (EMR) and Transanal Endoscopic Microsurgery (TEM)
Number of subjects: 24
Study 16822110 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based coping skills training (CST)
Number of subjects: 328
Study 16822110 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care (UMC)
Number of subjects: 328
Study 12464714 — intervention group
Group type: EXPERIMENTAL
Intervention: rizatriptan 10 mg
Number of subjects: 439
Study 12464714 — intervention group
Group type: COMPARATOR
Intervention: ergotamine 1 mg/caffeine 100 mg
Number of subjects: 439
Study 10888149 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 degree left lateral position
Number of subjects: 35
Study 10888149 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 35
Study 8803398 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 percent carbamide peroxide gel
Number of subjects: 52
Study 8803398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 1627717 — intervention group
Group type: COMPARATOR
Intervention: Letterbox drops (leaflets distributed to households)
Number of subjects: 3984
Study 1627717 — intervention group
Group type: COMPARATOR
Intervention: Invitations for friends (including pamphlet and contact information)
Number of subjects: 3984
Study 6371285 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural analgesia with bupivacaine (0.25% or 0.125%) and morphine (3 mg injected twice a day)
Number of subjects: 11
Study 6371285 — intervention group
Group type: COMPARATOR
Intervention: Epidural morphine (3 mg injected twice a day)
Number of subjects: 11
Study 31912485 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-based intervention (2 sessions)
Number of subjects: 133
Study 31912485 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 133
Study 31330252 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS 4-item scale
Number of subjects: 300
Study 31330252 — intervention group
Group type: EXPERIMENTAL
Intervention: Numeric Rating Scale (NRS)
Number of subjects: 300
Study 31330252 — intervention group
Group type: COMPARATOR
Intervention: Non-PROMIS legacy scale
Number of subjects: 300
Study 28152175 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline restricted life-space
Number of subjects: 478
Study 28152175 — intervention group
Group type: COMPARATOR
Intervention: Baseline unrestricted life-space
Number of subjects: 478
Study 25789616 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK933776 0.001-6 mg/kg (intravenous administration)
Number of subjects: 50
Study 23863537 — intervention group
Group type: COMPARATOR
Intervention: Transrectal ultrasound (TRUS) volumetry
Number of subjects: 46
Study 23863537 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) volumetry
Number of subjects: 46
Study 23863537 — intervention group
Group type: COMPARATOR
Intervention: TRUS versus MRI volumetry
Number of subjects: 46
Study 21411613 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics alone (Lactobacillus rhamnosus strains GG and LC705, Propionibacterium freudenreichii ssp. shermanii JS, and Bifidobacterium breve Bb99, 2 × 10(10) CFU/d)
Number of subjects: 18
Study 21411613 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics with GOS (3.8 g/d)
Number of subjects: 18
Study 21411613 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics with GOS and rye bread (minimum 120 g/d)
Number of subjects: 18
Study 21411613 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics with GOS
Number of subjects: 18
Study 21411613 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics alone
Number of subjects: 18
Study 19757002 — intervention group
Group type: EXPERIMENTAL
Intervention: CT scan of the left atrium and esophagus integrated into the 3D electroanatomical map
Number of subjects: 18
Study 19757002 — intervention group
Group type: COMPARATOR
Intervention: Esophagus tag integrated into the electroanatomic LA map
Number of subjects: 18
Study 17554100 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of evidence-based model for critically appraising research evidence
Number of subjects: 1
Study 17554100 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of letter grade scale for quality assessment
Number of subjects: 1
Study 17554100 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist-driven model for evidence application
Number of subjects: 1
Study 15515440 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental design intervention (large clock and sign with large lettering identifying mealtimes)
Number of subjects: 35
Study 11566459 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (200 mg daily) for 1 week followed by ketoprofen (200 mg daily) and aspirin (325 mg daily)
Number of subjects: 25
Study 11566459 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofen (200 mg daily) for 1 week followed by ketoprofen (200 mg daily) alone
Number of subjects: 25
Study 11566459 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (200 mg daily) with aspirin (325 mg daily)
Number of subjects: 25
Study 11566459 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofen (200 mg daily) without aspirin
Number of subjects: 25
Study 9745426 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen (ethinyl estradiol, 12.5-50 ng/kg.day)
Number of subjects: 2
Study 9745426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 7825702 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional meal preparation group (n = 23)
Number of subjects: 45
Study 7825702 — intervention group
Group type: COMPARATOR
Intervention: Parquetry block assembly group (n = 22)
Number of subjects: 45
Study 3373080 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone (DDS) injection
Number of subjects: 74
Study 3373080 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoacetyldapsone (MADDS) injection
Number of subjects: 74
Study 3373080 — intervention group
Group type: COMPARATOR
Intervention: Comparison of DDS and MADDS
Number of subjects: 74
Study 30465292 — intervention group
Group type: EXPERIMENTAL
Intervention: Divide-and-conquer technique (Group-1)
Number of subjects: 110
Study 30465292 — intervention group
Group type: EXPERIMENTAL
Intervention: Stop-and-chop technique (Group-2)
Number of subjects: 110
Study 30465292 — intervention group
Group type: COMPARATOR
Intervention: Stop-and-chop technique (in second part of study)
Number of subjects: 110
Study 30465292 — intervention group
Group type: COMPARATOR
Intervention: Divide-and-conquer technique (in second part of study)
Number of subjects: 110
Study 29024079 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide 5% gel or cream
Number of subjects: 0
Study 29024079 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin 0.025% cream
Number of subjects: 0
Study 29024079 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study 25909676 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanding transplants
Number of subjects: 0
Study 25909676 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic correction with local tissues
Number of subjects: 0
Study 25909676 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture correction technique
Number of subjects: 0
Study 24270291 — intervention group
Group type: EXPERIMENTAL
Intervention: Social environmental intervention
Number of subjects: 0
Study 24270291 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical environmental intervention
Number of subjects: 0
Study 24270291 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions
Number of subjects: 0
Study 24270291 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical intervention with social intervention
Number of subjects: 0
Study 21478286 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 0
Study 21478286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19349144 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFCA)
Number of subjects: 61
Study 16574999 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed dose of cisplatin in course 1
Number of subjects: 25
Study 16574999 — intervention group
Group type: EXPERIMENTAL
Intervention: BSA-adjusted dose of cisplatin in course 2
Number of subjects: 25
Study 16574999 — intervention group
Group type: COMPARATOR
Intervention: Normal population retrospective analysis
Number of subjects: 25
Study 15389743 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual laser therapy (LLLT)
Number of subjects: 60
Study 15389743 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser therapy
Number of subjects: 60
Study 11494959 — intervention group
Group type: EXPERIMENTAL
Intervention: sad with physical discomfort
Number of subjects: 139
Study 11494959 — intervention group
Group type: EXPERIMENTAL
Intervention: happy with physical discomfort
Number of subjects: 139
Study 11494959 — intervention group
Group type: COMPARATOR
Intervention: sad
Number of subjects: 139
Study 11494959 — intervention group
Group type: COMPARATOR
Intervention: happy
Number of subjects: 139
Study 9087156 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenugreek seed powder
Number of subjects: 2
Study 9087156 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin scratch test with fenugreek
Number of subjects: 2
Study 9087156 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoblotting with fenugreek extract
Number of subjects: 2
Study 8460803 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 10
Study 8460803 — intervention group
Group type: COMPARATOR
Intervention: Guedel airway, bag and facemask
Number of subjects: 10
Study 3817031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (high doses, orally administered)
Number of subjects: 0
Study 3817031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31114155 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) of amlodipine 10 mg/olmesartan 40 mg/rosuvastatin 20 mg
Number of subjects: 64
Study 31114155 — intervention group
Group type: COMPARATOR
Intervention: Co-administration of FDC (amlodipine 10 mg/olmesartan 40 mg) and rosuvastatin 20 mg
Number of subjects: 64
Study 31114155 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 64
Study 30142622 — intervention group
Group type: EXPERIMENTAL
Intervention: Serving
Number of subjects: 30
Study 26621551 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone Monitoring and Counseling (TMC)
Number of subjects: 321
Study 26621551 — intervention group
Group type: EXPERIMENTAL
Intervention: TMC-plus
Number of subjects: 321
Study 26621551 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 321
Study 25375054 — intervention group
Group type: EXPERIMENTAL
Intervention: Human fibrin glue (HFG)
Number of subjects: 468
Study 25375054 — intervention group
Group type: COMPARATOR
Intervention: Suture polypropylene fixation
Number of subjects: 468
Study 22487627 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligasure
Number of subjects: 40
Study 22487627 — intervention group
Group type: COMPARATOR
Intervention: Clip
Number of subjects: 40
Study 20491709 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g EPA for 15 weeks
Number of subjects: 92
Study 18587509 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback device
Number of subjects: 33
Study 18587509 — intervention group
Group type: COMPARATOR
Intervention: Traditional physiotherapy intervention
Number of subjects: 33
Study 16157232 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational group counseling followed by cognitive-behavioral group (12 sessions, 3 times per week for 4 weeks, followed by 36 sessions, 3 times per week for 12 weeks) plus information and referral (I&R) and peer advocacy
Number of subjects: 289
Study 16157232 — intervention group
Group type: COMPARATOR
Intervention: Information and referral (I&R) plus peer advocacy
Number of subjects: 289
Study 16157232 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational group counseling followed by cognitive-behavioral group plus I&R and peer advocacy
Number of subjects: 289
Study 11948003 — intervention group
Group type: COMPARATOR
Intervention: 1000 mg ER
Number of subjects: 36
Study 11948003 — intervention group
Group type: COMPARATOR
Intervention: 1500 mg ER
Number of subjects: 36
Study 11948003 — intervention group
Group type: COMPARATOR
Intervention: ER formulation
Number of subjects: 36
Study 11948003 — intervention group
Group type: COMPARATOR
Intervention: Higher ER doses
Number of subjects: 36
Study 10319779 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure and acupuncture (study group)
Number of subjects: 100
Study 10319779 — intervention group
Group type: COMPARATOR
Intervention: Placebo (non-bead Acubands, control group)
Number of subjects: 100
Study 8682824 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamed nailing
Number of subjects: 50
Study 8682824 — intervention group
Group type: COMPARATOR
Intervention: Unreamed nailing
Number of subjects: 50
Study 1932837 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor response
Number of subjects: 0
Study 1932837 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase II trials
Number of subjects: 0
Study 1932837 — intervention group
Group type: COMPARATOR
Intervention: Phase III comparative trials
Number of subjects: 0
Study 7053922 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide (1 mg/kg)
Number of subjects: 19
Study 7053922 — intervention group
Group type: COMPARATOR
Intervention: Chlorthiazid (10 mg/Kg)
Number of subjects: 19
Study 7053922 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide (0.25‐0.5 mg/Kg)
Number of subjects: 19
Study 7053922 — intervention group
Group type: COMPARATOR
Intervention: Chlorthiazid (20 mg/Kg)
Number of subjects: 19
Study 31374063 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% cyclosporine ophthalmic emulsion (CsA OE)
Number of subjects: 240
Study 31374063 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 240
Study 29021370 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition-focused MNCH
Number of subjects: 1300
Study 29021370 — intervention group
Group type: COMPARATOR
Intervention: Standard MNCH
Number of subjects: 1300
Study 26149189 — intervention group
Group type: EXPERIMENTAL
Intervention: l-carnitine 750 mg/d for 8 weeks
Number of subjects: 72
Study 26149189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 23311715 — intervention group
Group type: EXPERIMENTAL
Intervention: Carprofen
Number of subjects: 68
Study 23311715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 21659360 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine, Chlorambucil, and Fludarabine with Cyclophosphamide as first-line treatment
Number of subjects: 356
Study 18022303 — intervention group
Group type: EXPERIMENTAL
Intervention: Left motor deficits (LPD)
Number of subjects: 35